NEW YORK, Nov. 3, 2022 /PRNewswire/ --
Abstract:
What’s New for 2022?
Global competitiveness and key competitor percentage market shares
Read the full report:
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year
Global Single-Cell Genome Sequencing Market to Reach $4.3 Billion by 2027
In the changed post COVID-19 business landscape, the global market for Single-Cell Genome Sequencing estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at aCAGR of 13.2% over the period 2020-2027. Instruments, one of the segments analyzed in the report, is projected to record 13.8% CAGR and reach US$2.7 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Reagents segment is readjusted to a revised 12.3% CAGR for the next 7-year period.
The U.S. Market is Estimated at $529.3 Million, While China is Forecast to Grow at 12.6% CAGR
The Single-Cell Genome Sequencing market in the U.S. is estimated at US$529.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$749.6 Million by the year 2027 trailing a CAGR of 12.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 11.6% and 10.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.9% CAGR.
Select Competitors (Total 33 Featured) -
10x Genomics
Agilent Technologies, Inc.
BGI
Bio-Rad Laboratories
DNA Electronics Ltd.
F Hoffmann-La Roche Ltd.
Fluidigm
Illumina, Inc.
Johnson & Johnson
Novogene
Oxford Nanopore Technologies
Pacific Biosciences
QIAGEN
Thermo Fisher Scientific, Inc.
Zephyrus Biosciences Inc.
Read the full report:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Single-Cell Genome Sequencing - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Single-Cell Genome
Sequencing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 3: World 15-Year Perspective for Single-Cell Genome
Sequencing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2021 & 2027
Table 4: World Recent Past, Current & Future Analysis for
Instruments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 5: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for
Reagents by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 8: World Historic Review for Reagents by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Reagents by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2021 & 2027
Table 10: World Recent Past, Current & Future Analysis for
Clinics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 11: World Historic Review for Clinics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Clinics by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 14: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 15: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 16: World Recent Past, Current & Future Analysis for
Academic & Research Labs by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 17: World Historic Review for Academic & Research Labs by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 18: World 15-Year Perspective for Academic & Research
Labs by Geographic Region - Percentage Breakdown of Value Sales
for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 19: World Recent Past, Current & Future Analysis for
Biotech & Biopharma Companies by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for Biotech & Biopharma
Companies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 21: World 15-Year Perspective for Biotech & Biopharma
Companies by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2021 & 2027
Table 22: World Recent Past, Current & Future Analysis for NGS
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 23: World Historic Review for NGS by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for NGS by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2021 & 2027
Table 25: World Recent Past, Current & Future Analysis for PCR
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 26: World Historic Review for PCR by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for PCR by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2021 & 2027
Table 28: World Recent Past, Current & Future Analysis for qPCR
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 29: World Historic Review for qPCR by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 30: World 15-Year Perspective for qPCR by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2021 & 2027
Table 31: World Recent Past, Current & Future Analysis for
Microarray by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 32: World Historic Review for Microarray by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2012 through 2019 and % CAGR
Table 33: World 15-Year Perspective for Microarray by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2021 & 2027
Table 34: World Recent Past, Current & Future Analysis for MDA
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 and
% CAGR
Table 35: World Historic Review for MDA by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 36: World 15-Year Perspective for MDA by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2021 & 2027
Table 37: World Single-Cell Genome Sequencing Market Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Single-Cell Genome Sequencing Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United States for 2022
(E)
Table 38: USA Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Product - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 39: USA Historic Review for Single-Cell Genome Sequencing
by Product - Instruments and Reagents Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 40: USA 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2021 & 2027
Table 41: USA Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by End-Use - Clinics, Other
End-Uses, Academic & Research Labs and Biotech & Biopharma
Companies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 42: USA Historic Review for Single-Cell Genome Sequencing
by End-Use - Clinics, Other End-Uses, Academic & Research Labs
and Biotech & Biopharma Companies Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 43: USA 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2021 & 2027
Table 44: USA Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR,
Microarray and MDA - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 45: USA Historic Review for Single-Cell Genome Sequencing
by Technology - NGS, PCR, qPCR, Microarray and MDA Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 46: USA 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2021 &
2027
CANADA
Table 47: Canada Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Product - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 48: Canada Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 49: Canada 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2021 & 2027
Table 50: Canada Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by End-Use - Clinics, Other
End-Uses, Academic & Research Labs and Biotech & Biopharma
Companies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 51: Canada Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 52: Canada 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2021 & 2027
Table 53: Canada Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR,
Microarray and MDA - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 54: Canada Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 55: Canada 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2021 &
2027
JAPAN
Single-Cell Genome Sequencing Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 56: Japan Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Product - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 57: Japan Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 58: Japan 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2021 & 2027
Table 59: Japan Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by End-Use - Clinics, Other
End-Uses, Academic & Research Labs and Biotech & Biopharma
Companies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 60: Japan Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 61: Japan 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2021 & 2027
Table 62: Japan Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR,
Microarray and MDA - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 63: Japan Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 64: Japan 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2021 &
2027
CHINA
Single-Cell Genome Sequencing Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in China for 2022 (E)
Table 65: China Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Product - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 66: China Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 67: China 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2021 & 2027
Table 68: China Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by End-Use - Clinics, Other
End-Uses, Academic & Research Labs and Biotech & Biopharma
Companies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 69: China Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 70: China 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2021 & 2027
Table 71: China Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR,
Microarray and MDA - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 72: China Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 73: China 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2021 &
2027
EUROPE
Single-Cell Genome Sequencing Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 74: Europe Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Geographic Region - France,
Germany, Italy, UK and Rest of Europe Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 75: Europe Historic Review for Single-Cell Genome
Sequencing by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 76: Europe 15-Year Perspective for Single-Cell Genome
Sequencing by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2021 & 2027
Table 77: Europe Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Product - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 78: Europe Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 79: Europe 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2021 & 2027
Table 80: Europe Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by End-Use - Clinics, Other
End-Uses, Academic & Research Labs and Biotech & Biopharma
Companies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 81: Europe Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 82: Europe 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2021 & 2027
Table 83: Europe Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR,
Microarray and MDA - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 84: Europe Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 85: Europe 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2021 &
2027
FRANCE
Single-Cell Genome Sequencing Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in France for 2022 (E)
Table 86: France Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Product - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 87: France Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 88: France 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2021 & 2027
Table 89: France Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by End-Use - Clinics, Other
End-Uses, Academic & Research Labs and Biotech & Biopharma
Companies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 90: France Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 91: France 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2021 & 2027
Table 92: France Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR,
Microarray and MDA - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 93: France Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 94: France 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2021 &
2027
GERMANY
Single-Cell Genome Sequencing Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in Germany for 2022 (E)
Table 95: Germany Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Product - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 96: Germany Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 97: Germany 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2021 & 2027
Table 98: Germany Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by End-Use - Clinics, Other
End-Uses, Academic & Research Labs and Biotech & Biopharma
Companies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 99: Germany Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 100: Germany 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2021 & 2027
Table 101: Germany Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR,
Microarray and MDA - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 102: Germany Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 103: Germany 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2021 &
2027
ITALY
Table 104: Italy Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Product - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 105: Italy Historic Review for Single-Cell Genome
Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 106: Italy 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2021 & 2027
Table 107: Italy Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by End-Use - Clinics, Other
End-Uses, Academic & Research Labs and Biotech & Biopharma
Companies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 108: Italy Historic Review for Single-Cell Genome
Sequencing by End-Use - Clinics, Other End-Uses, Academic &
Research Labs and Biotech & Biopharma Companies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 109: Italy 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2021 & 2027
Table 110: Italy Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR,
Microarray and MDA - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 111: Italy Historic Review for Single-Cell Genome
Sequencing by Technology - NGS, PCR, qPCR, Microarray and MDA
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 112: Italy 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2021 &
2027
UNITED KINGDOM
Single-Cell Genome Sequencing Market Presence - Strong/Active/
Niche/Trivial - Key Competitors in the United Kingdom for 2022
(E)
Table 113: UK Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Product - Instruments and
Reagents - Independent Analysis of Annual Sales in US$ Thousand
for the Years 2020 through 2027 and % CAGR
Table 114: UK Historic Review for Single-Cell Genome Sequencing
by Product - Instruments and Reagents Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 115: UK 15-Year Perspective for Single-Cell Genome
Sequencing by Product - Percentage Breakdown of Value Sales for
Instruments and Reagents for the Years 2012, 2021 & 2027
Table 116: UK Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by End-Use - Clinics, Other
End-Uses, Academic & Research Labs and Biotech & Biopharma
Companies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 117: UK Historic Review for Single-Cell Genome Sequencing
by End-Use - Clinics, Other End-Uses, Academic & Research Labs
and Biotech & Biopharma Companies Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2019 and % CAGR
Table 118: UK 15-Year Perspective for Single-Cell Genome
Sequencing by End-Use - Percentage Breakdown of Value Sales for
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies for the Years 2012, 2021 & 2027
Table 119: UK Recent Past, Current & Future Analysis for
Single-Cell Genome Sequencing by Technology - NGS, PCR, qPCR,
Microarray and MDA - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 120: UK Historic Review for Single-Cell Genome Sequencing
by Technology - NGS, PCR, qPCR, Microarray and MDA Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 121: UK 15-Year Perspective for Single-Cell Genome
Sequencing by Technology - Percentage Breakdown of Value Sales
for NGS, PCR, qPCR, Microarray and MDA for the Years 2012, 2021 &
2027
REST OF EUROPE
Table 122: Rest of Europe Recent Past, Current & Future
Analysis for Single-Cell Genome Sequencing by Product -
Instruments and Reagents - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 123: Rest of Europe Historic Review for Single-Cell
Genome Sequencing by Product - Instruments and Reagents Markets -
Independent Analysis of Annual Sales in US$ Thousand for
Years 2012 through 2019 and % CAGR
Table 124: Rest of Europe 15-Year Perspective for Single-Cell
Genome Sequencing by Product - Percentage Breakdown of Value
Sales for Instruments and Reagents for the Years 2012, 2021 &
2027
Table 125: Rest of Europe Recent Past, Current & Future
Analysis for Single-Cell Genome Sequencing by End-Use -
Clinics, Other End-Uses, Academic & Research Labs and Biotech &
Biopharma Companies - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR
Table 126: Rest of Europe Historic Review for Single-Cell
Genome Sequencing by End-Use - Clinics, Other End-Uses,
Academic & Research Labs and Biotech & Biopharma Companies
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR
Table 127: Rest of Europe 15-Year Perspective for Single-Cell
Genome Sequencing by End-Use - Percentage Breakdown of Value
Sales for Clinics, Other End-Uses, Academic & Research Labs and
Biotech & Biopharma Companies for the Years 2012, 2021 & 2027
Table 128: Rest of Europe Recent Past, Current & Future
Analysis for Single-Cell Genome Sequencing by Technology - NGS,
PCR, qPCR, Microarray and MDA - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 and %
CAGR
Table 129: Rest of Europe Historic Review for Single-Cell
Genome Sequencing by Technology - NGS, PCR, qPCR, Microarray
and MDA Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 130: Rest of Europe 15-Year Perspective for Single-Cell
Genome Sequencing by Technology - Percentage Breakdown of Value
Sales for NGS, PCR, qPCR, Microarray and MDA for the Years
2012, 2021 & 2027
ASIA-PACIFIC
Single-Cell Genome Sequencing Market Presence - Strong/Active/
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report:
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker